title: Reply to T. Hasegawa et al and I. Gross et al.
authors: Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Els Vercammen and Liang Xiu, Janssen Research & Development, Raritan, NJ.
authors: Brian
authors: B
authors: Leyland-Jones
authors: Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Els Vercammen and Liang Xiu, Janssen Research & Development, Raritan, NJ.
authors: Els
authors: E
authors: Vercammen
authors: Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Els Vercammen and Liang Xiu, Janssen Research & Development, Raritan, NJ.
authors: Liang
authors: L
authors: Xiu